CNI-1493 prolongs survival and reduces myocyte loss, apoptosis, and inflammation during rat cardiac allograft rejection

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 1, 1998, Pages 146-155

  Yang, Xiaochun ^a   Szabolcs, Mathias ^a   Minanov, Oktavijan ^a   Ma, Ningsheng ^a   Sciacca, Robert R ^a   Bianchi, Marina ^b   Tracey, Kevin J ^b   Michler, Robert E ^a   Cannon, Paul J ^a,c  

^a College of Physicians and Surgeons ^*  (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Allograft; CNI 1493; Macrophage; Rejection

Indexed keywords

AMINOGUANIDINE; CYTOKINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; SEMAPIMOD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE MIGRATION INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ENZYME INDUCTION; GRAFT REJECTION; HEART TRANSPLANTATION; HYDRAZONES; MALE; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEINS; RATS; RATS, INBRED LEW; RATS, INBRED WF; RNA, MESSENGER;

EID: 0031800038     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199807000-00023     Document Type: Article

References (37)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
2. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
3. Hall BM. Cells mediating allograft rejection. Transplantation 1991;51:1141-51.
4. Wu C, Lovett M, Wong-hee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992;54:326-32.
5. Yang X, Chowdhury N, Cai B, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994;94: 714-21.
6. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 1995;95:677-85.
7. Szabolcs M, Michler RE, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation 1996;94:1665-73.
8. Bianchi M, Ulrich P, Bloom O, et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammatory andendotoxin lethality. Mol Med 1995;1(3):254-66.
9. Bianchi M, Bloom O, Raabe T, et al. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 1996;83:927-36.
10. Leudke CE, Cerami A. Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest 1990;86:1234-40.
11. Ono K, Lindsay ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;7:225-9.
12. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 1992;119:493-501.
13. Riedy MC, Timm EA Jr, Steward CC. Quantitative RT-PCR for measuring gene expression. Biotechniques 1995;18:70-6.
14. Wu X, Shang A, Jiang H, Ginsberg HN. Low rates of apo E secretion from Hep G 2 cells result from reduced delivery of newly synthesized triglyceride to a "secretion-coupled" pool. J Lipid Res 1996;37:1198-205.
15. Arends MJ, Wyllie AH. Apoptosis mechanisms and roles in pathology. Int Res Exp Pathol 1991;32:223-54.
16. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
17. Gottlieb RA, Berleson KO, Kloner RA, Bablor BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-8.
18. Suzuki H, Wildhirl SM, Dudek RR, Narayan KS, Bailey GH, Bing RJ. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tissue Cell 1996;28(1):89-97.
19. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
20. Bing OH. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 1994;26:943-8.
21. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994;90:556-73.
22. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;335:1190-6.
23. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in endstage heart failure. N Engl J Med 1996;335:1182-9.
24. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
25. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-59.
26. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150: 5080-5.
27. Pinsky DJ, Yang X, Aji W, Sciacca RR, Cannon PJ. Nitric oxide induces apoptosis of adult rat cardiac myocytes [Abstract]. Circulation 1995;92:I-565.
28. Szabolcs M, Ravalli S, Minanov OP, Sciacca R, Michler RE, Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998;65:804-12.
29. Bjork L, Fehniger T, Andersson U, Andersson J. Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. J Leukoc Biol 1996;59:287-95.
30. Lec JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1995;372:739-46.
31. Cohen PS, Dennis J, Sherry B, et al. p38 Mitogen-activated protein kinase (MAPK) participates in T lymphocyte co-stimulation [Abstract]. Blood 1997;88(I):465a.
32. Cohen PS, Nakshastri H, Dennis J, et al. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci USA 1996;93:3967-71.
33. Wang H, Zhang M, Cerami C, Sherry B, Tracey KJ. A macrophage-secreted protein mediates the macrophage-pacifying activity of CNI-1493 [Abstract]. Shock 1997;7:92.
34. Wang H, Zhang M, Soda K, Sams A, Tracey KJ. Fetuin protects the fetus from TNF. Lancet 1997;350:861.
35. Meistrell III ME, Botchkina GI, Wang H, et al. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock 1997;8:5, 341-8.
36. Zhang M, Caragine T, Wang H, et al. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counter regulatory mechanism that restrains the immune response. J Exp Med 1997;185:10, 1759-68.
37. Tracey KJ. Suppression of TNF and other proinflammatory cytokines by the tetravalent guanylhydrazone CNI-1493: endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance and therapy. New York: Wiley-Liss (in press).